Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas-Reference-Cited by-同舟云学术

Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas

Published:2014-06-01 Issue:7 Volume:46 Page:726-730
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Zhang Liwei,Chen Lee H,Wan Hong,Yang Rui,Wang Zhaohui,Feng Jie,Yang Shaohua,Jones Siân,Wang Sizhen,Zhou Weixin,Zhu Huishan,Killela Patrick J,Zhang Junting,Wu Zhen,Li Guilin,Hao Shuyu,Wang Yu,Webb Joseph B,Friedman Henry S,Friedman Allan H,McLendon Roger E,He Yiping,Reitman Zachary J,Bigner Darell D,Yan Hai

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.2995.pdf

Reference32 articles.

1. Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226–231 (2012).

2. Khuong-Quang, D.A. et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 124, 439–447 (2012).

3. Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44, 251–253 (2012).

4. Puget, S. et al. Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS ONE 7, e30313 (2012).

5. Jones, D.T. et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat. Genet. 45, 927–932 (2013).

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPM1D truncation-associated overexpression of the stress-related protein NQO1 confers sensitivity to the bioactivatable drug IB-DNQ in diffuse intrinsic pontine glioma;2024-09-06

2. PPM1D activity promotes cellular transformation by preventing senescence and cell death;Oncogene;2024-09-05

3. Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy;Cancer Letters;2024-08

4. Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment;Journal of Advanced Research;2024-08

5. Diagnostic potential of vitreoretinal lymphoma by detection of gene mutations with NGS in 25 Chinese patients;Clinica Chimica Acta;2024-07